{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:11:13Z","timestamp":1793067073714,"version":"4.5.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["Grant No. 2025ZNSFSC1799"],"award-info":[{"award-number":["Grant No. 2025ZNSFSC1799"]}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["Grant No. 25MSZX550"],"award-info":[{"award-number":["Grant No. 25MSZX550"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05886-w","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:56:02Z","timestamp":1777420562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CD33 Isoform Splicing Dysregulation: A Molecular Determinant of Microglial Dysfunction in Alzheimer\u2019s Disease Pathology"],"prefix":"10.1007","volume":"63","author":[{"given":"Xiao-Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"2","key":"5886_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, Abdoli A, Abualhasan A et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7(2):e105\u2013e125","journal-title":"Lancet Public Health"},{"key":"5886_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","volume":"4","author":"PP Liu","year":"2019","unstructured":"Liu PP, Xie Y, Meng XY, Kang JS (2019) History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct Target Ther 4:29. https:\/\/doi.org\/10.1038\/s41392-019-0063-8","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"5886_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","journal-title":"Cell"},{"issue":"4","key":"5886_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R et al (2022) New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54(4):412\u2013436. https:\/\/doi.org\/10.1038\/s41588-022-01024-z","journal-title":"Nat Genet"},{"issue":"3","key":"5886_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, Sealock J, Karlsson IK et al (2019) Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet 51(3):404\u2013413. https:\/\/doi.org\/10.1038\/s41588-018-0311-9","journal-title":"Nat Genet"},{"issue":"1","key":"5886_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295008","volume":"19","author":"F Kong","year":"2024","unstructured":"Kong F, Wu T, Dai J, Cai J, Zhai Z, Zhu Z, Xu Y, Sun T (2024) Knowledge domains and emerging trends of genome-wide association studies in Alzheimer\u2019s disease: a bibliometric analysis and visualization study from 2002 to 2022. PLoS ONE 19(1):e0295008. https:\/\/doi.org\/10.1371\/journal.pone.0295008","journal-title":"PLoS ONE"},{"issue":"4","key":"5886_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s11011-022-00953-2","volume":"37","author":"RAL De Sousa","year":"2022","unstructured":"De Sousa RAL (2022) Reactive gliosis in Alzheimer\u2019s disease: a crucial role for cognitive impairment and memory loss. Metab Brain Dis 37(4):851\u2013857. https:\/\/doi.org\/10.1007\/s11011-022-00953-2","journal-title":"Metab Brain Dis"},{"key":"5886_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbi.2015.07.021","volume":"55","author":"A ElAli","year":"2016","unstructured":"ElAli A, Rivest S (2016) Microglia in Alzheimer\u2019s disease: a multifaceted relationship. Brain Behav Immun 55:138\u2013150. https:\/\/doi.org\/10.1016\/j.bbi.2015.07.021","journal-title":"Brain Behav Immun"},{"issue":"1","key":"5886_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-022-01410-y","volume":"10","author":"S Lam","year":"2022","unstructured":"Lam S, H\u00e9rard AS, Boluda S, Petit F, Eddarkaoui S, Cambon K, Picq JL, Bu\u00e9e L et al (2022) Pathological changes induced by Alzheimer\u2019s brain inoculation in amyloid-beta plaque-bearing mice. Acta Neuropathol Commun 10(1):112. https:\/\/doi.org\/10.1186\/s40478-022-01410-y","journal-title":"Acta Neuropathol Commun"},{"key":"5886_CR10","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-G\u00f3mez JA, Kavanagh E, Engskog-Vlachos P, Engskog MKR, Herrera AJ, Espinosa-Oliva AM, Joseph B, Hajji N, Venero JL et al\u00a0(2020) Microglia: agents of the CNS pro-inflammatory response. Cells, 9(7). https:\/\/doi.org\/10.3390\/cells9071717","DOI":"10.3390\/cells9071717"},{"key":"5886_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073330","author":"M Eshraghi","year":"2021","unstructured":"Eshraghi M, Adlimoghaddam A, Mahmoodzadeh A, Sharifzad F, Yasavoli-Sharahi H, Lorzadeh S, Albensi BC, Ghavami S (2021) Alzheimer\u2019s disease pathogenesis: role of autophagy and mitophagy focusing in microglia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22073330","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5886_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-019-02000-4","volume":"138","author":"S Estus","year":"2019","unstructured":"Estus S, Shaw BC, Devanney N, Katsumata Y, Press EE, Fardo DW (2019) Evaluation of CD33 as a genetic risk factor for Alzheimer\u2019s disease. Acta Neuropathol 138(2):187\u2013199. https:\/\/doi.org\/10.1007\/s00401-019-02000-4","journal-title":"Acta Neuropathol"},{"key":"5886_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","volume":"38","author":"S Duan","year":"2020","unstructured":"Duan S, Paulson JC (2020) Siglecs as immune cell checkpoints in disease. Annu Rev Immunol 38:365\u2013395. https:\/\/doi.org\/10.1146\/annurev-immunol-102419-035900","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"5886_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nri3737","volume":"14","author":"MS Macauley","year":"2014","unstructured":"Macauley MS, Crocker PR, Paulson JC (2014) Siglec-mediated regulation of immune cell function in disease. Nat Rev Immunol 14(10):653\u2013666. https:\/\/doi.org\/10.1038\/nri3737","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"5886_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00251-009-0372-0","volume":"61","author":"H Cao","year":"2009","unstructured":"Cao H, de Bono B, Belov K, Wong ES, Trowsdale J, Barrow AD (2009) Comparative genomics indicates the mammalian CD33rSiglec locus evolved by an ancient large-scale inverse duplication and suggests all Siglecs share a common ancestral region. Immunogenetics 61(5):401\u2013417. https:\/\/doi.org\/10.1007\/s00251-009-0372-0","journal-title":"Immunogenetics"},{"issue":"30","key":"5886_CR16","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1039\/d0ob01116a","volume":"18","author":"LD Movsisyan","year":"2020","unstructured":"Movsisyan LD, Macauley MS (2020) Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation. Org Biomol Chem 18(30):5784\u20135797. https:\/\/doi.org\/10.1039\/d0ob01116a","journal-title":"Org Biomol Chem"},{"issue":"4","key":"5886_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"PR Crocker","year":"2007","unstructured":"Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7(4):255\u2013266. https:\/\/doi.org\/10.1038\/nri2056","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"5886_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood.V96.2.483.014k40_483_490","volume":"96","author":"SP Paul","year":"2000","unstructured":"Paul SP, Taylor LS, Stansbury EK, McVicar DW (2000) Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood 96(2):483\u2013490","journal-title":"Blood"},{"issue":"10","key":"5886_CR19","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/hmg\/ddt666","volume":"23","author":"T Raj","year":"2014","unstructured":"Raj T, Ryan KJ, Replogle JM, Chibnik LB, Rosenkrantz L, Tang A, Rothamel K, Stranger BE et al (2014) CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer\u2019s disease susceptibility. Hum Mol Genet 23(10):2729\u20132736. https:\/\/doi.org\/10.1093\/hmg\/ddt666","journal-title":"Hum Mol Genet"},{"issue":"12","key":"5886_CR20","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.carres.2008.01.009","volume":"343","author":"SJ McMillan","year":"2008","unstructured":"McMillan SJ, Crocker PR (2008) CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease. Carbohydr Res 343(12):2050\u20132056. https:\/\/doi.org\/10.1016\/j.carres.2008.01.009","journal-title":"Carbohydr Res"},{"issue":"6","key":"5886_CR21","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1039\/c4sc00451e","volume":"5","author":"CD Rillahan","year":"2014","unstructured":"Rillahan CD, Macauley MS, Schwartz E, He Y, McBride R, Arlian BM, Rangarajan J, Fokin VV et al (2014) Disubstituted sialic acid ligands targeting Siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas. Chem Sci 5(6):2398\u20132406. https:\/\/doi.org\/10.1039\/c4sc00451e","journal-title":"Chem Sci"},{"issue":"1","key":"5886_CR22","doi-asserted-by":"publisher","first-page":"1r","DOI":"10.1093\/glycob\/cwj008","volume":"16","author":"A Varki","year":"2006","unstructured":"Varki A, Angata T (2006) Siglecs\u2013the major subfamily of I-type lectins. Glycobiology 16(1):1r\u201327r. https:\/\/doi.org\/10.1093\/glycob\/cwj008","journal-title":"Glycobiology"},{"issue":"1","key":"5886_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1189\/jlb.0205096","volume":"79","author":"T Hern\u00e1ndez-Caselles","year":"2006","unstructured":"Hern\u00e1ndez-Caselles T, Mart\u00ednez-Esparza M, P\u00e9rez-Oliva AB, Quintanilla-Cecconi AM, Garc\u00eda-Alonso A, Alvarez-L\u00f3pez DM, Garc\u00eda-Pe\u00f1arrubia P (2006) A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing. J Leukoc Biol 79(1):46\u201358. https:\/\/doi.org\/10.1189\/jlb.0205096","journal-title":"J Leukoc Biol"},{"key":"5886_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1749-6632.2011.06449.x","volume":"1253","author":"PR Crocker","year":"2012","unstructured":"Crocker PR, McMillan SJ, Richards HE (2012) CD33-related siglecs as potential modulators of inflammatory responses. Ann N Y Acad Sci 1253:102\u2013111. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06449.x","journal-title":"Ann N Y Acad Sci"},{"key":"5886_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev-immunol-020711-075018","volume":"30","author":"S Pillai","year":"2012","unstructured":"Pillai S, Netravali IA, Cariappa A, Mattoo H (2012) Siglecs and immune regulation. Annu Rev Immunol 30:357\u2013392. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075018","journal-title":"Annu Rev Immunol"},{"key":"5886_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-020-00428-w","volume":"10","author":"M Jiang","year":"2020","unstructured":"Jiang M, Ye J, Wang X, Li N, Wang Y, Shi Y (2020) Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1\/STAT3 and P38 signals. Cell Biosci 10:65. https:\/\/doi.org\/10.1186\/s13578-020-00428-w","journal-title":"Cell Biosci"},{"issue":"6","key":"5886_CR27","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/glia.23968","volume":"69","author":"J Wi\u00dffeld","year":"2021","unstructured":"Wi\u00dffeld J, Nozaki I, Mathews M, Raschka T, Ebeling C, Hornung V, Br\u00fcstle O, Neumann H (2021) Deletion of Alzheimer\u2019s disease-associated CD33 results in an inflammatory human microglia phenotype. Glia 69(6):1393\u20131412. https:\/\/doi.org\/10.1002\/glia.23968","journal-title":"Glia"},{"issue":"1","key":"5886_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/acsmedchemlett.1c00396","volume":"13","author":"TA Chappie","year":"2022","unstructured":"Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM et al (2022) Discovery of small-molecule CD33 Pre-mRNA splicing modulators. ACS Med Chem Lett 13(1):55\u201362. https:\/\/doi.org\/10.1021\/acsmedchemlett.1c00396","journal-title":"ACS Med Chem Lett"},{"issue":"5","key":"5886_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML et al (2011) Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet 43(5):429\u2013435. https:\/\/doi.org\/10.1038\/ng.803","journal-title":"Nat Genet"},{"issue":"4","key":"5886_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH et al (2013) Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78(4):631\u2013643. https:\/\/doi.org\/10.1016\/j.neuron.2013.04.014","journal-title":"Neuron"},{"issue":"7","key":"5886_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00109-009-0472-1","volume":"87","author":"A Salminen","year":"2009","unstructured":"Salminen A, Kaarniranta K (2009) Siglec receptors and hiding plaques in Alzheimer\u2019s disease. J Mol Med (Berl) 87(7):697\u2013701. https:\/\/doi.org\/10.1007\/s00109-009-0472-1","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"5886_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02205-4","volume":"12","author":"X Gu","year":"2022","unstructured":"Gu X, Dou M, Cao B, Jiang Z, Chen Y (2022) Peripheral level of CD33 and Alzheimer\u2019s disease: a bidirectional two-sample Mendelian randomization study. Transl Psychiatry 12(1):427. https:\/\/doi.org\/10.1038\/s41398-022-02205-4","journal-title":"Transl Psychiatry"},{"issue":"33","key":"5886_CR33","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.1523\/jneurosci.1224-13.2013","volume":"33","author":"M Malik","year":"2013","unstructured":"Malik M, Simpson JF, Parikh I, Wilfred BR, Fardo DW, Nelson PT, Estus S (2013) CD33 Alzheimer\u2019s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci 33(33):13320\u201313325. https:\/\/doi.org\/10.1523\/jneurosci.1224-13.2013","journal-title":"J Neurosci"},{"key":"5886_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neulet.2015.10.007","volume":"609","author":"YF Mao","year":"2015","unstructured":"Mao YF, Guo ZY, Pu JL, Chen YX, Zhang BR (2015) Association of CD33 and MS4A cluster variants with Alzheimer\u2019s disease in East Asian populations. Neurosci Lett 609:235\u2013239. https:\/\/doi.org\/10.1016\/j.neulet.2015.10.007","journal-title":"Neurosci Lett"},{"key":"5886_CR35","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17339","volume":"12","author":"R Hossain","year":"2024","unstructured":"Hossain R, Noonong K, Nuinoon M, Lao-On U, Norris CM, Sompol P, Rahman MA, Majima HJ et al (2024) Alzheimer\u2019s diseases in America, Europe, and Asian regions: a global genetic variation. PeerJ 12:e17339. https:\/\/doi.org\/10.7717\/peerj.17339","journal-title":"PeerJ"},{"issue":"1","key":"5886_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00734-8","volume":"19","author":"G Eskandari-Sedighi","year":"2024","unstructured":"Eskandari-Sedighi G, Crichton M, Zia S, Gomez-Cardona E, Cortez LM, Patel ZH, Takahashi-Yamashiro K, St Laurent CD et al (2024) Alzheimer\u2019s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice. Mol Neurodegener 19(1):42. https:\/\/doi.org\/10.1186\/s13024-024-00734-8","journal-title":"Mol Neurodegener"},{"key":"5886_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040602","author":"R Komuro","year":"2023","unstructured":"Komuro R, Honda Y, Yanaizu M, Nagahama M, Kino Y (2023) Alzheimer\u2019s disease-associated alternative splicing of CD33 is regulated by the HNRNPA family proteins. Cells. https:\/\/doi.org\/10.3390\/cells12040602","journal-title":"Cells"},{"issue":"23","key":"5886_CR38","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1200\/jco.2016.71.2513","volume":"35","author":"JK Lamba","year":"2017","unstructured":"Lamba JK, Chauhan L, Shin M, Loken MR, Pollard JA, Wang YC, Ries RE, Aplenc R et al (2017) CD33 splicing polymorphism determines gemtuzumab ozogamicin response in de novo acute myeloid leukemia: report from randomized Phase III Children\u2019s Oncology Group trial AAML0531. J Clin Oncol 35(23):2674\u20132682. https:\/\/doi.org\/10.1200\/jco.2016.71.2513","journal-title":"J Clin Oncol"},{"key":"5886_CR39","doi-asserted-by":"publisher","unstructured":"Tortora F, Rendina A, Angiolillo A, Di Costanzo A, Aniello F, Donizetti A, Febbraio F, Vitale E (2022) CD33 rs2455069 SNP: correlation with Alzheimer\u2019s disease and hypothesis of functional role. Int J Mol Sci, 23(7). https:\/\/doi.org\/10.3390\/ijms23073629","DOI":"10.3390\/ijms23073629"},{"issue":"12","key":"5886_CR40","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1093\/hmg\/ddv092","volume":"24","author":"M Malik","year":"2015","unstructured":"Malik M, Chiles J 3rd, Xi HS, Medway C, Simpson J, Potluri S, Howard D, Liang Y et al (2015) Genetics of CD33 in Alzheimer\u2019s disease and acute myeloid leukemia. Hum Mol Genet 24(12):3557\u20133570. https:\/\/doi.org\/10.1093\/hmg\/ddv092","journal-title":"Hum Mol Genet"},{"issue":"9","key":"5886_CR41","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1080\/10428194.2019.1569232","volume":"60","author":"I Papageorgiou","year":"2019","unstructured":"Papageorgiou I, Loken MR, Brodersen LE, Gbadamosi M, Uy GL, Meshinchi S, Lamba JK (2019) CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agents. Leuk Lymphoma 60(9):2287\u20132290. https:\/\/doi.org\/10.1080\/10428194.2019.1569232","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"5886_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21963-1","volume":"12","author":"WJ Li","year":"2021","unstructured":"Li WJ, He YH, Yang JJ, Hu GS, Lin YA, Ran T, Peng BL, Xie BL et al (2021) Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth. Nat Commun 12(1):1946. https:\/\/doi.org\/10.1038\/s41467-021-21963-1","journal-title":"Nat Commun"},{"issue":"12","key":"5886_CR43","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41374-020-0466-8","volume":"100","author":"A Gupta","year":"2020","unstructured":"Gupta A, Yadav S, Pt A, Mishra J, Samaiya A, Panday RK, Shukla S (2020) The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer. Lab Invest 100(12):1589\u20131601. https:\/\/doi.org\/10.1038\/s41374-020-0466-8","journal-title":"Lab Invest"},{"issue":"1","key":"5886_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01066-6","volume":"14","author":"F Jiang","year":"2021","unstructured":"Jiang F, Tang X, Tang C, Hua Z, Ke M, Wang C, Zhao J, Gao S et al (2021) HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA. J Hematol Oncol 14(1):54. https:\/\/doi.org\/10.1186\/s13045-021-01066-6","journal-title":"J Hematol Oncol"},{"key":"5886_CR45","doi-asserted-by":"publisher","unstructured":"Kim MK, Choi MJ, Lee HM, Choi HS, Park YK, Ryu CJ (2021) Heterogeneous nuclear ribonucleoprotein A2\/B1 regulates the ERK and p53\/HDM2 signaling pathways to promote the survival, proliferation and migration of non\u2011small cell lung cancer cells. Oncol Rep, 46(2). https:\/\/doi.org\/10.3892\/or.2021.8104","DOI":"10.3892\/or.2021.8104"},{"issue":"3","key":"5886_CR46","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3892\/or.2018.6195","volume":"39","author":"X Shi","year":"2018","unstructured":"Shi X, Ran L, Liu Y, Zhong SH, Zhou PP, Liao MX, Fang W (2018) Knockdown of hnRNP A2\/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K\/AKT signaling pathway. Oncol Rep 39(3):939\u2013950. https:\/\/doi.org\/10.3892\/or.2018.6195","journal-title":"Oncol Rep"},{"issue":"1","key":"5886_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20674-3","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Lloyd SM, Kweon J, Gamalong GM, Bao X (2021) Epidermal progenitors suppress GRHL3-mediated differentiation through intronic polyadenylation promoted by CPSF-HNRNPA3 collaboration. Nat Commun 12(1):448. https:\/\/doi.org\/10.1038\/s41467-020-20674-3","journal-title":"Nat Commun"},{"issue":"1","key":"5886_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3892\/ol.2020.12307","volume":"21","author":"X Ren","year":"2021","unstructured":"Ren X, Dong Y, Duan M, Zhang H, Gao P (2021) Abnormal expression of HNRNPA3 in multistep hepatocarcinogenesis. Oncol Lett 21(1):46. https:\/\/doi.org\/10.3892\/ol.2020.12307","journal-title":"Oncol Lett"},{"issue":"1","key":"5886_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-019-02082-0","volume":"139","author":"Y Nihei","year":"2020","unstructured":"Nihei Y, Mori K, Werner G, Arzberger T, Zhou Q, Khosravi B, Japtok J, Hermann A et al (2020) Poly-glycine-alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3. Acta Neuropathol 139(1):99\u2013118. https:\/\/doi.org\/10.1007\/s00401-019-02082-0","journal-title":"Acta Neuropathol"},{"issue":"7","key":"5886_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119506","volume":"1870","author":"HL Liu","year":"2023","unstructured":"Liu HL, Lu XM, Wang HY, Hu KB, Wu QY, Liao P, Li S, Long ZY et al (2023) The role of RNA splicing factor PTBP1 in neuronal development. Biochim Biophys Acta Mol Cell Res 1870(7):119506. https:\/\/doi.org\/10.1016\/j.bbamcr.2023.119506","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"5886_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04905-x","author":"Q Yu","year":"2023","unstructured":"Yu Q, Wu T, Xu W, Wei J, Zhao A, Wang M, Li M, Chi G (2023) PTBP1 as a potential regulator of disease. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-023-04905-x","journal-title":"Mol Cell Biochem"},{"key":"5886_CR52","doi-asserted-by":"publisher","unstructured":"van Bergeijk P, Seneviratne U, Aparicio-Prat E, Stanton R, Hasson SA (2019) SRSF1 and PTBP1 are trans-acting factors that suppress the formation of a CD33 splicing isoform linked to Alzheimer\u2019s disease risk. Mol Cell Biol, 39(18). https:\/\/doi.org\/10.1128\/mcb.00568-18","DOI":"10.1128\/mcb.00568-18"},{"issue":"5","key":"5886_CR53","doi-asserted-by":"publisher","first-page":"653","DOI":"10.15252\/embj.201489852","volume":"34","author":"MB Coelho","year":"2015","unstructured":"Coelho MB, Attig J, Bellora N, K\u00f6nig J, Hallegger M, Kayikci M, Eyras E, Ule J et al (2015) Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB. Embo j 34(5):653\u2013668. https:\/\/doi.org\/10.15252\/embj.201489852","journal-title":"Embo j"},{"issue":"1","key":"5886_CR54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-021-00495-6","volume":"6","author":"Y Lv","year":"2021","unstructured":"Lv Y, Zhang W, Zhao J, Sun B, Qi Y, Ji H, Chen C, Zhang J et al (2021) SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer. Signal Transduct Target Ther 6(1):108. https:\/\/doi.org\/10.1038\/s41392-021-00495-6","journal-title":"Signal Transduct Target Ther"},{"issue":"15","key":"5886_CR55","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.7150\/ijbs.83474","volume":"19","author":"WL Lei","year":"2023","unstructured":"Lei WL, Li YY, Du Z, Su R, Meng TG, Ning Y, Hou G, Schatten H et al (2023) SRSF1-mediated alternative splicing is required for spermatogenesis. Int J Biol Sci 19(15):4883\u20134897. https:\/\/doi.org\/10.7150\/ijbs.83474","journal-title":"Int J Biol Sci"},{"issue":"11","key":"5886_CR56","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00018-023-04979-2","volume":"80","author":"X Yao","year":"2023","unstructured":"Yao X, Wang C, Yu W, Sun L, Lv Z, Xie X, Tian S, Yan L et al (2023) SRSF1 is essential for primary follicle development by regulating granulosa cell survival via mRNA alternative splicing. Cell Mol Life Sci 80(11):343. https:\/\/doi.org\/10.1007\/s00018-023-04979-2","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"5886_CR57","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1158\/2159-8290.Cd-22-1013","volume":"13","author":"L Wan","year":"2023","unstructured":"Wan L, Lin KT, Rahman MA, Ishigami Y, Wang Z, Jensen MA, Wilkinson JE, Park Y et al (2023) Splicing factor SRSF1 promotes pancreatitis and KRASG12D-mediated pancreatic cancer. Cancer Discov 13(7):1678\u20131695. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-1013","journal-title":"Cancer Discov"},{"key":"5886_CR58","doi-asserted-by":"publisher","unstructured":"Qu Y, He Y, Wang Y, Han Z, Qin L (2023) Targeted down-regulation of SRSF1 exerts anti-cancer activity in OSCC through impairing lysosomal function and autophagy. iScience, 26(12):108330. https:\/\/doi.org\/10.1016\/j.isci.2023.108330","DOI":"10.1016\/j.isci.2023.108330"},{"issue":"2","key":"5886_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29439","volume":"96","author":"L Guo","year":"2024","unstructured":"Guo L, Liu JJ, Long SY, Wang PY, Li S, Wang JL, Wei XF, Li J et al (2024) TIM22 and TIM29 inhibit HBV replication by up-regulating SRSF1 expression. J Med Virol 96(2):e29439. https:\/\/doi.org\/10.1002\/jmv.29439","journal-title":"J Med Virol"},{"issue":"9","key":"5886_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010973","volume":"19","author":"S Krupp","year":"2023","unstructured":"Krupp S, Hubbard I, Tam O, Hammell GM, Dubnau J (2023) TDP-43 pathology in Drosophila induces glial-cell type specific toxicity that can be ameliorated by knock-down of SF2\/SRSF1. PLoS Genet 19(9):e1010973. https:\/\/doi.org\/10.1371\/journal.pgen.1010973","journal-title":"PLoS Genet"},{"issue":"37","key":"5886_CR61","doi-asserted-by":"publisher","first-page":"15312","DOI":"10.1074\/jbc.M117.799346","volume":"292","author":"SS Siddiqui","year":"2017","unstructured":"Siddiqui SS, Springer SA, Verhagen A, Sundaramurthy V, Alisson-Silva F, Jiang W, Ghosh P, Varki A (2017) The Alzheimer\u2019s disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool. J Biol Chem 292(37):15312\u201315320. https:\/\/doi.org\/10.1074\/jbc.M117.799346","journal-title":"J Biol Chem"},{"issue":"2","key":"5886_CR62","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jnc.15349","volume":"158","author":"CA Butler","year":"2021","unstructured":"Butler CA, Thornton P, Brown GC (2021) CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer\u2019s disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion. J Neurochem 158(2):297\u2013310. https:\/\/doi.org\/10.1111\/jnc.15349","journal-title":"J Neurochem"},{"issue":"1","key":"5886_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-021-00443-6","volume":"16","author":"A Bhattacherjee","year":"2021","unstructured":"Bhattacherjee A, Jung J, Zia S, Ho M, Eskandari-Sedighi G, St Laurent CD, McCord KA, Bains A et al (2021) The CD33 short isoform is a gain-of-function variant that enhances A\u03b2(1\u201342) phagocytosis in microglia. Mol Neurodegener 16(1):19. https:\/\/doi.org\/10.1186\/s13024-021-00443-6","journal-title":"Mol Neurodegener"},{"issue":"12","key":"5886_CR64","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1128\/mcb.23.12.4199-4206.2003","volume":"23","author":"EC Brinkman-Van der Linden","year":"2003","unstructured":"Brinkman-Van der Linden EC, Angata T, Reynolds SA, Powell LD, Hedrick SM, Varki A (2003) CD33\/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol Cell Biol 23(12):4199\u20134206. https:\/\/doi.org\/10.1128\/mcb.23.12.4199-4206.2003","journal-title":"Mol Cell Biol"},{"key":"5886_CR65","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s42003-019-0698-6","volume":"2","author":"A Bhattacherjee","year":"2019","unstructured":"Bhattacherjee A, Rodrigues E, Jung J, Luzentales-Simpson M, Enterina JR, Galleguillos D, St Laurent CD, Nakhaei-Nejad M et al (2019) Repression of phagocytosis by human CD33 is not conserved with mouse CD33. Commun Biol 2:450. https:\/\/doi.org\/10.1038\/s42003-019-0698-6","journal-title":"Commun Biol"},{"issue":"1","key":"5886_CR66","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12974-017-0816-7","volume":"14","author":"S Krishnasamy","year":"2017","unstructured":"Krishnasamy S, Weng YC, Thammisetty SS, Phaneuf D, Lalancette-Hebert M, Kriz J (2017) Molecular imaging of nestin in neuroinflammatory conditions reveals marked signal induction in activated microglia. J Neuroinflammation 14(1):45. https:\/\/doi.org\/10.1186\/s12974-017-0816-7","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5886_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00674-9","volume":"18","author":"G Terzioglu","year":"2023","unstructured":"Terzioglu G, Young-Pearse TL (2023) Microglial function, INPP5D\/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer\u2019s disease. Mol Neurodegener 18(1):89. https:\/\/doi.org\/10.1186\/s13024-023-00674-9","journal-title":"Mol Neurodegener"},{"issue":"8","key":"5886_CR68","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 19(8):987\u2013991. https:\/\/doi.org\/10.1038\/nn.4338","journal-title":"Nat Neurosci"},{"issue":"7","key":"5886_CR69","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276-1290.e1217. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"issue":"2","key":"5886_CR70","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, Pluvinage JV, Mathur V et al (2020) Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci 23(2):194\u2013208. https:\/\/doi.org\/10.1038\/s41593-019-0566-1","journal-title":"Nat Neurosci"},{"issue":"1","key":"5886_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00440-9","volume":"16","author":"K Clayton","year":"2021","unstructured":"Clayton K, Delpech JC, Herron S, Iwahara N, Ericsson M, Saito T, Saido TC, Ikezu S et al (2021) Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model. Mol Neurodegener 16(1):18. https:\/\/doi.org\/10.1186\/s13024-021-00440-9","journal-title":"Mol Neurodegener"},{"issue":"4","key":"5886_CR72","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, Mancuso R, Chen WT et al (2019) The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep 27(4):1293-1306.e1296. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.099","journal-title":"Cell Rep"},{"issue":"6","key":"5886_CR73","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","volume":"23","author":"FL Yeh","year":"2017","unstructured":"Yeh FL, Hansen DV, Sheng M (2017) TREM2, microglia, and neurodegenerative diseases. Trends Mol Med 23(6):512\u2013533. https:\/\/doi.org\/10.1016\/j.molmed.2017.03.008","journal-title":"Trends Mol Med"},{"issue":"11","key":"5886_CR74","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nn.4126","volume":"18","author":"G Chan","year":"2015","unstructured":"Chan G, White CC, Winn PA, Cimpean M, Replogle JM, Glick LR, Cuerdon NE, Ryan KJ et al (2015) CD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci 18(11):1556\u20131558. https:\/\/doi.org\/10.1038\/nn.4126","journal-title":"Nat Neurosci"},{"issue":"5","key":"5886_CR75","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK, Cereghetti G, McGinty D et al (2019) TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron 103(5):820-835.e827. https:\/\/doi.org\/10.1016\/j.neuron.2019.06.010","journal-title":"Neuron"},{"issue":"2","key":"5886_CR76","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jmb.2007.05.069","volume":"371","author":"T Okada","year":"2007","unstructured":"Okada T, Wakabayashi M, Ikeda K, Matsuzaki K (2007) Formation of toxic fibrils of Alzheimer\u2019s amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J Mol Biol 371(2):481\u2013489. https:\/\/doi.org\/10.1016\/j.jmb.2007.05.069","journal-title":"J Mol Biol"},{"issue":"3","key":"5886_CR77","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/bf03036452","volume":"7","author":"MD Martin-Rehrmann","year":"2005","unstructured":"Martin-Rehrmann MD, Hoe HS, Capuani EM, Rebeck GW (2005) Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer\u2019s disease brain. Neurotox Res 7(3):231\u2013242. https:\/\/doi.org\/10.1007\/bf03036452","journal-title":"Neurotox Res"},{"issue":"7","key":"5886_CR78","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S et al (2013) CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci 16(7):848\u2013850. https:\/\/doi.org\/10.1038\/nn.3435","journal-title":"Nat Neurosci"},{"issue":"7751","key":"5886_CR79","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41586-019-1088-4","volume":"568","author":"JV Pluvinage","year":"2019","unstructured":"Pluvinage JV, Haney MS, Smith BAH, Sun J, Iram T, Bonanno L, Li L, Lee DP et al (2019) CD22 blockade restores homeostatic microglial phagocytosis in ageing brains. Nature 568(7751):187\u2013192. https:\/\/doi.org\/10.1038\/s41586-019-1088-4","journal-title":"Nature"},{"issue":"5","key":"5886_CR80","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/glia.23757","volume":"68","author":"DH Allendorf","year":"2020","unstructured":"Allendorf DH, Puigdell\u00edvol M, Brown GC (2020) Activated microglia desialylate their surface, stimulating complement receptor 3-mediated phagocytosis of neurons. Glia 68(5):989\u2013998. https:\/\/doi.org\/10.1002\/glia.23757","journal-title":"Glia"},{"key":"5886_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24613","author":"G Cuevas-Rios","year":"2024","unstructured":"Cuevas-Rios G, Assale TA, Wissfeld J, Bungartz A, Hofmann J, Langmann T, Neumann H (2024) Decreased sialylation elicits complement-related microglia response and bipolar cell loss in the mouse retina. Glia. https:\/\/doi.org\/10.1002\/glia.24613","journal-title":"Glia"},{"key":"5886_CR82","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neurobiolaging.2020.01.008","volume":"88","author":"C Klaus","year":"2020","unstructured":"Klaus C, Hansen JN, Ginolhac A, G\u00e9rard D, Gnanapragassam VS, Horstkorte R, Rossdam C, Buettner FFR et al (2020) Reduced sialylation triggers homeostatic synapse and neuronal loss in middle-aged mice. Neurobiol Aging 88:91\u2013107. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.01.008","journal-title":"Neurobiol Aging"},{"issue":"14","key":"5886_CR83","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1074\/jbc.M116.764357","volume":"292","author":"A Minami","year":"2017","unstructured":"Minami A, Meguro Y, Ishibashi S, Ishii A, Shiratori M, Sai S, Horii Y, Shimizu H et al (2017) Rapid regulation of sialidase activity in response to neural activity and sialic acid removal during memory processing in rat hippocampus. J Biol Chem 292(14):5645\u20135654. https:\/\/doi.org\/10.1074\/jbc.M116.764357","journal-title":"J Biol Chem"},{"issue":"10","key":"5886_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165257","volume":"11","author":"A Minami","year":"2016","unstructured":"Minami A, Saito M, Mamada S, Ieno D, Hikita T, Takahashi T, Otsubo T, Ikeda K et al (2016) Role of sialidase in long-term potentiation at Mossy Fiber-CA3 synapses and hippocampus-dependent spatial memory. PLoS ONE 11(10):e0165257. https:\/\/doi.org\/10.1371\/journal.pone.0165257","journal-title":"PLoS ONE"},{"key":"5886_CR85","doi-asserted-by":"publisher","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, Llapashtica C, Wang J\u00a0\u00a0et al\u00a0(2020) TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron\u00a0105(5):837\u2013854.e839. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.007","DOI":"10.1016\/j.neuron.2019.12.007"},{"issue":"5","key":"5886_CR86","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, Sun Y, Zhu B et al (2018) TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron 97(5):1023-1031.e1027. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.031","journal-title":"Neuron"},{"issue":"3","key":"5886_CR87","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1084\/jem.20171529","volume":"215","author":"WM Song","year":"2018","unstructured":"Song WM, Joshita S, Zhou Y, Ulland TK, Gilfillan S, Colonna M (2018) Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J Exp Med 215(3):745\u2013760. https:\/\/doi.org\/10.1084\/jem.20171529","journal-title":"J Exp Med"},{"issue":"2","key":"5886_CR88","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/glia.24485","volume":"72","author":"J Penney","year":"2024","unstructured":"Penney J, Ralvenius WT, Loon A, Cerit O, Dileep V, Milo B, Pao PC, Woolf H et al (2024) iPSC-derived microglia carrying the TREM2 R47H\/+ mutation are proinflammatory and promote synapse loss. Glia 72(2):452\u2013469. https:\/\/doi.org\/10.1002\/glia.24485","journal-title":"Glia"},{"issue":"4","key":"5886_CR89","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/glia.24318","volume":"71","author":"AS Popescu","year":"2023","unstructured":"Popescu AS, Butler CA, Allendorf DH, Piers TM, Mallach A, Roewe J, Reinhardt P, Cinti A et al (2023) Alzheimer\u2019s disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss. Glia 71(4):974\u2013990. https:\/\/doi.org\/10.1002\/glia.24318","journal-title":"Glia"},{"issue":"8","key":"5886_CR90","doi-asserted-by":"publisher","first-page":"10984","DOI":"10.1096\/fj.202000550RR","volume":"34","author":"Z Rong","year":"2020","unstructured":"Rong Z, Cheng B, Zhong L, Ye X, Li X, Jia L, Li Y, Shue F et al (2020) Activation of FAK\/Rac1\/Cdc42-GTPase signaling ameliorates impaired microglial migration response to A\u03b2(42) in triggering receptor expressed on myeloid cells 2 loss-of-function murine models. Faseb j 34(8):10984\u201310997. https:\/\/doi.org\/10.1096\/fj.202000550RR","journal-title":"Faseb j"},{"issue":"3","key":"5886_CR91","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/jad-231159","volume":"98","author":"Z Shen","year":"2024","unstructured":"Shen Z, Yang X, Lan Y, Chen G (2024) The neuro-inflammatory microenvironment: an important regulator of stem cell survival in Alzheimer\u2019s disease. J Alzheimers Dis 98(3):741\u2013754. https:\/\/doi.org\/10.3233\/jad-231159","journal-title":"J Alzheimers Dis"},{"key":"5886_CR92","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-genet-112618-043515","volume":"53","author":"CJ Bohlen","year":"2019","unstructured":"Bohlen CJ, Friedman BA, Dejanovic B, Sheng M (2019) Microglia in brain development, homeostasis, and neurodegeneration. Annu Rev Genet 53:263\u2013288. https:\/\/doi.org\/10.1146\/annurev-genet-112618-043515","journal-title":"Annu Rev Genet"},{"issue":"13","key":"5886_CR93","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1038\/npp.2014.164","volume":"39","author":"T Jiang","year":"2014","unstructured":"Jiang T, Tan L, Zhu XC, Zhang QQ, Cao L, Tan MS, Gu LZ, Wang HF et al (2014) Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 39(13):2949\u20132962. https:\/\/doi.org\/10.1038\/npp.2014.164","journal-title":"Neuropsychopharmacology"},{"key":"5886_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainresbull.2020.10.006","volume":"166","author":"X Cui","year":"2021","unstructured":"Cui X, Qiao J, Liu S, Wu M, Gu W (2021) Mechanism of TREM2\/DAP12 complex affecting \u03b2-amyloid plaque deposition in Alzheimer\u2019s disease modeled mice through mediating inflammatory response. Brain Res Bull 166:21\u201328. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.10.006","journal-title":"Brain Res Bull"},{"issue":"1","key":"5886_CR95","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuron.2016.09.016","volume":"92","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, Luo W, Colonna M et al (2016) TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 92(1):252\u2013264. https:\/\/doi.org\/10.1016\/j.neuron.2016.09.016","journal-title":"Neuron"},{"key":"5886_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1420731","volume":"16","author":"C Lin","year":"2024","unstructured":"Lin C, Kong Y, Chen Q, Zeng J, Pan X, Miao J (2024) Decoding sTREM2: its impact on Alzheimer\u2019s disease - a comprehensive review of mechanisms and implications. Front Aging Neurosci 16:1420731. https:\/\/doi.org\/10.3389\/fnagi.2024.1420731","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"5886_CR97","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.neurol.2023.12.006","volume":"180","author":"G Nicolas","year":"2024","unstructured":"Nicolas G (2024) Lessons from genetic studies in Alzheimer disease. Rev Neurol (Paris) 180(5):368\u2013377. https:\/\/doi.org\/10.1016\/j.neurol.2023.12.006","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"5886_CR98","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y et al (2017) TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170(4):649-663.e613. https:\/\/doi.org\/10.1016\/j.cell.2017.07.023","journal-title":"Cell"},{"issue":"5","key":"5886_CR99","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","volume":"97","author":"CYD Lee","year":"2018","unstructured":"Lee CYD, Daggett A, Gu X, Jiang LL, Langfelder P, Li X, Wang N, Zhao Y et al (2018) Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models. Neuron 97(5):1032-1048.e1035. https:\/\/doi.org\/10.1016\/j.neuron.2018.02.002","journal-title":"Neuron"},{"key":"5886_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105809","volume":"171","author":"C Cao","year":"2022","unstructured":"Cao C, Ding J, Cao D, Li B, Wu J, Li X, Li H, Cui G et al (2022) TREM2 modulates neuroinflammation with elevated IRAK3 expression and plays a neuroprotective role after experimental SAH in rats. Neurobiol Dis 171:105809. https:\/\/doi.org\/10.1016\/j.nbd.2022.105809","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5886_CR101","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-020-01853-x","volume":"17","author":"S Chen","year":"2020","unstructured":"Chen S, Peng J, Sherchan P, Ma Y, Xiang S, Yan F, Zhao H, Jiang Y et al (2020) TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K\/Akt pathway after intracerebral hemorrhage in mice. J Neuroinflammation 17(1):168. https:\/\/doi.org\/10.1186\/s12974-020-01853-x","journal-title":"J Neuroinflammation"},{"issue":"5","key":"5886_CR102","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.neuron.2019.08.019","volume":"103","author":"TY Huang","year":"2019","unstructured":"Huang TY, Xu H (2019) Bringing order out of chaos: establishing an epistatic relationship between CD33 and TREM2. Neuron 103(5):747\u2013749. https:\/\/doi.org\/10.1016\/j.neuron.2019.08.019","journal-title":"Neuron"},{"issue":"4","key":"5886_CR103","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn.2016.7","volume":"17","author":"M Colonna","year":"2016","unstructured":"Colonna M, Wang Y (2016) TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci 17(4):201\u2013207. https:\/\/doi.org\/10.1038\/nrn.2016.7","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"5886_CR104","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/ni.1744","volume":"10","author":"K Otero","year":"2009","unstructured":"Otero K, Turnbull IR, Poliani PL, Vermi W, Cerutti E, Aoshi T, Tassi I, Takai T et al (2009) Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol 10(7):734\u2013743. https:\/\/doi.org\/10.1038\/ni.1744","journal-title":"Nat Immunol"},{"key":"5886_CR105","doi-asserted-by":"publisher","unstructured":"Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB (2010) TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal, 3(122): ra38. https:\/\/doi.org\/10.1126\/scisignal.2000500","DOI":"10.1126\/scisignal.2000500"},{"issue":"6","key":"5886_CR106","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s11596-020-2281-2","volume":"40","author":"CC Zhu","year":"2020","unstructured":"Zhu CC, Fu SY, Chen YX, Li L, Mao RL, Wang JZ, Liu R, Liu Y et al (2020) Advances in drug therapy for Alzheimer\u2019s disease. Curr Med Sci 40(6):999\u20131008. https:\/\/doi.org\/10.1007\/s11596-020-2281-2","journal-title":"Curr Med Sci"},{"issue":"1","key":"5886_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01441-8","volume":"16","author":"LS Honig","year":"2024","unstructured":"Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, Giorgi L, Gee M et al (2024) Updated safety results from phase 3 lecanemab study in early Alzheimer\u2019s disease. Alzheimers Res Ther 16(1):105. https:\/\/doi.org\/10.1186\/s13195-024-01441-8","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"5886_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70905","volume":"21","author":"CH van Dyck","year":"2025","unstructured":"van Dyck CH, Sperling R, Johnson K, Dhadda S, Kanekiyo M, Li D, Gee M, Hersch S et al (2025) Long-term safety and efficacy of lecanemab in early Alzheimer\u2019s disease: results from the clarity AD open-label extension study. Alzheimers Dement 21(12):e70905. https:\/\/doi.org\/10.1002\/alz.70905","journal-title":"Alzheimers Dement"},{"issue":"18_supplement","key":"5886_CR109","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.98.18_supplement.3582","volume":"98","author":"D Maslyar","year":"2022","unstructured":"Maslyar D, Paul R, Long H, Rhinn H, Tassi I, Morrison G, Yeh F, Schwabe T et al (2022) A phase 1 study of AL003 in healthy volunteers and participants with Alzheimer\u2019s disease (P5-3.002). Neurology 98(18_supplement):3582","journal-title":"Neurology"},{"key":"5886_CR110","doi-asserted-by":"publisher","first-page":"1330874","DOI":"10.3389\/fneur.2024.1330874","volume":"15","author":"J Wi\u00dffeld","year":"2024","unstructured":"Wi\u00dffeld J, Abou Assale T, Cuevas-Rios G, Liao H, Neumann H (2024) Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases. Front Neurol 15:1330874. https:\/\/doi.org\/10.3389\/fneur.2024.1330874","journal-title":"Front Neurol"},{"key":"5886_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02474-z","author":"E Wong","year":"2024","unstructured":"Wong E, Malviya M, Jain T, Liao GP, Kehs Z, Chang JC, Studer L, Scheinberg DA et al (2024) HuM195 and its single-chain variable fragment increase A\u03b2 phagocytosis in microglia via elimination of CD33 inhibitory signaling. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-024-02474-z","journal-title":"Mol Psychiatry"},{"key":"5886_CR112","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.isci.2019.07.023","volume":"19","author":"LA Miles","year":"2019","unstructured":"Miles LA, Hermans SJ, Crespi GAN, Gooi JH, Doughty L, Nero TL, Markuli\u0107 J, Ebneth A et al (2019) Small molecule binding to Alzheimer risk factor CD33 promotes A\u03b2 phagocytosis. iScience 19:110\u2013118. https:\/\/doi.org\/10.1016\/j.isci.2019.07.023","journal-title":"iScience"},{"issue":"1","key":"5886_CR113","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13195-024-01599-1","volume":"16","author":"H Long","year":"2024","unstructured":"Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B, Rychkova A, Rhinn H et al (2024) Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer\u2019s disease. Alzheimers Res Ther 16(1):235. https:\/\/doi.org\/10.1186\/s13195-024-01599-1","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"5886_CR114","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41593-022-01240-0","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, Tatarakis D, Calvert M et al (2023) A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci 26(3):416\u2013429. https:\/\/doi.org\/10.1038\/s41593-022-01240-0","journal-title":"Nat Neurosci"},{"key":"5886_CR115","doi-asserted-by":"publisher","unstructured":"Mirescu C (2024) Characterization of the first TREM2 small molecule agonist, VG-3927, for clinical development in Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia\u00a020(S6):e084622. https:\/\/doi.org\/10.1002\/alz.084622","DOI":"10.1002\/alz.084622"},{"issue":"661","key":"5886_CR116","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang L, Fan X, Li L, Li X, Arase H, Zhao Y et al (2022) A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med 14(661):eabq0095","journal-title":"Sci Transl Med"},{"key":"5886_CR117","doi-asserted-by":"publisher","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, Willem M, Werner G\u00a0et al\u00a0(2020) Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med\u00a012(4):e11227. https:\/\/doi.org\/10.15252\/emmm.201911227","DOI":"10.15252\/emmm.201911227"},{"key":"5886_CR118","doi-asserted-by":"publisher","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, Ward M, Siddiqui O\u00a0et al\u00a0(2020) Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med\u00a0217(9). https:\/\/doi.org\/10.1084\/jem.20200785","DOI":"10.1084\/jem.20200785"},{"key":"5886_CR119","unstructured":"Padda IS, Parmar M (2024) Aducanumab. In StatPearls. StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC"},{"issue":"17","key":"5886_CR120","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1093\/hmg\/ddaa179","volume":"29","author":"A Griciuc","year":"2020","unstructured":"Griciuc A, Federico AN, Natasan J, Forte AM, McGinty D, Nguyen H, Volak A, LeRoy S et al (2020) Gene therapy for Alzheimer\u2019s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Hum Mol Genet 29(17):2920\u20132935. https:\/\/doi.org\/10.1093\/hmg\/ddaa179","journal-title":"Hum Mol Genet"},{"issue":"3","key":"5886_CR121","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, Richman LK, Wilson JM (2018) Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum Gene Ther 29(3):285\u2013298. https:\/\/doi.org\/10.1089\/hum.2018.015","journal-title":"Hum Gene Ther"},{"key":"5886_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101112","volume":"90","author":"MA Stanczak","year":"2023","unstructured":"Stanczak MA, L\u00e4ubli H (2023) Siglec receptors as new immune checkpoints in cancer. Mol Aspects Med 90:101112. https:\/\/doi.org\/10.1016\/j.mam.2022.101112","journal-title":"Mol Aspects Med"},{"issue":"12","key":"5886_CR123","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/glia.24073","volume":"69","author":"H Liao","year":"2021","unstructured":"Liao H, Winkler J, Wi\u00dffeld J, Shahraz A, Klaus C, Neumann H (2021) Low molecular weight polysialic acid prevents lipopolysaccharide-induced inflammatory dopaminergic neurodegeneration in humanized SIGLEC11 transgenic mice. Glia 69(12):2845\u20132862. https:\/\/doi.org\/10.1002\/glia.24073","journal-title":"Glia"},{"key":"5886_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106079","volume":"180","author":"H Varbanov","year":"2023","unstructured":"Varbanov H, Jia S, Kochlamazashvili G, Bhattacharya S, Buabeid MA, El Tabbal M, Hayani H, Stoyanov S et al (2023) Rescue of synaptic and cognitive functions in polysialic acid-deficient mice and dementia models by short polysialic acid fragments. Neurobiol Dis 180:106079. https:\/\/doi.org\/10.1016\/j.nbd.2023.106079","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5886_CR125","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1038\/s41467-020-18907-6","volume":"11","author":"E Rodrigues","year":"2020","unstructured":"Rodrigues E, Jung J, Park H, Loo C, Soukhtehzari S, Kitova EN, Mozaneh F, Daskhan G et al (2020) A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands. Nat Commun 11(1):5091. https:\/\/doi.org\/10.1038\/s41467-020-18907-6","journal-title":"Nat Commun"},{"issue":"2","key":"5886_CR126","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12264-011-1205-3","volume":"27","author":"Y Feng","year":"2011","unstructured":"Feng Y, Li L, Sun XH (2011) Monocytes and Alzheimer\u2019s disease. Neurosci Bull 27(2):115\u2013122. https:\/\/doi.org\/10.1007\/s12264-011-1205-3","journal-title":"Neurosci Bull"},{"key":"5886_CR127","doi-asserted-by":"publisher","unstructured":"Tamucci K (2024) Genetic variation of the Alzheimer\u2019s disease risk gene CD33 modifies microglial immunometabolism. Alzheimer\u2019s & Dementia\u00a020(S1):e088368. https:\/\/doi.org\/10.1002\/alz.088368","DOI":"10.1002\/alz.088368"},{"issue":"11","key":"5886_CR128","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1007\/s11064-019-02890-6","volume":"44","author":"K Sandoval","year":"2019","unstructured":"Sandoval K, Umbaugh D, House A, Crider A, Witt K (2019) Somatostatin receptor subtype-4 regulates mRNA expression of amyloid-beta degrading enzymes and microglia mediators of phagocytosis in brains of 3xTg-AD mice. Neurochem Res 44(11):2670\u20132680. https:\/\/doi.org\/10.1007\/s11064-019-02890-6","journal-title":"Neurochem Res"},{"issue":"3","key":"5886_CR129","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s11064-021-03482-z","volume":"47","author":"A Silwal","year":"2022","unstructured":"Silwal A, House A, Sandoval K, Vijeth S, Umbaugh D, Crider A, Mobayen S, Neumann W et al (2022) Novel somatostatin receptor-4 agonist SM-I-26 mitigates lipopolysaccharide-induced inflammatory gene expression in microglia. Neurochem Res 47(3):768\u2013780. https:\/\/doi.org\/10.1007\/s11064-021-03482-z","journal-title":"Neurochem Res"},{"issue":"3","key":"5886_CR130","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.apsb.2023.10.009","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, Yang P, Meng R, Xu S, Zhou L, Qian K, Wang P, Cheng Y et al (2024) Multidimensional autophagy nano-regulator boosts Alzheimer\u2019s disease treatment by improving both extra\/intraneuronal homeostasis. Acta Pharm Sin B 14(3):1380\u20131399. https:\/\/doi.org\/10.1016\/j.apsb.2023.10.009","journal-title":"Acta Pharm Sin B"},{"issue":"18","key":"5886_CR131","doi-asserted-by":"publisher","first-page":"17845","DOI":"10.1021\/acsnano.3c03390","volume":"17","author":"S Sun","year":"2023","unstructured":"Sun S, Lv W, Li S, Zhang Q, He W, Min Z, Teng C, Chen Y et al (2023) Smart liposomal nanocarrier enhanced the treatment of ischemic stroke through neutrophil extracellular traps and cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) pathway inhibition of ischemic penumbra. ACS Nano 17(18):17845\u201317857. https:\/\/doi.org\/10.1021\/acsnano.3c03390","journal-title":"ACS Nano"},{"issue":"9","key":"5886_CR132","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13255","volume":"55","author":"H Chen","year":"2022","unstructured":"Chen H, Jayasinghe MK, Yeo EYM, Wu Z, Pirisinu M, Usman WM, Pham TT, Lim KW et al (2022) CD33-targeting extracellular vesicles deliver antisense oligonucleotides against FLT3-ITD and miR-125b for specific treatment of acute myeloid leukaemia. Cell Prolif 55(9):e13255. https:\/\/doi.org\/10.1111\/cpr.13255","journal-title":"Cell Prolif"},{"issue":"6","key":"5886_CR133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130419","volume":"10","author":"KM Hayden","year":"2015","unstructured":"Hayden KM, Lutz MW, Kuchibhatla M, Germain C, Plassman BL (2015) Effect of APOE and CD33 on cognitive decline. PLoS ONE 10(6):e0130419. https:\/\/doi.org\/10.1371\/journal.pone.0130419","journal-title":"PLoS ONE"},{"key":"5886_CR134","doi-asserted-by":"publisher","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD\u00a0et al\u00a0(2011) Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet\u00a043(5):436\u2013441. https:\/\/doi.org\/10.1038\/ng.801","DOI":"10.1038\/ng.801"},{"issue":"9","key":"5886_CR135","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s12276-020-00503-9","volume":"52","author":"DS Jo","year":"2020","unstructured":"Jo DS, Park NY, Cho DH (2020) Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases. Exp Mol Med 52(9):1486\u20131495. https:\/\/doi.org\/10.1038\/s12276-020-00503-9","journal-title":"Exp Mol Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05886-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:56:04Z","timestamp":1777420564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05886-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":135,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5886"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05886-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"593"}}